Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A proof-of-concept automated method for accurate skin dosimetry: correcting overestimated surface dose measurements.

Physics in medicine and biology·2026
Same author

Development and validation of an automated, accurate in-house treatment planning system for pencil-beam scanning carbon ion radiotherapy.

Medical physics·2026
Same author

Real-time energy measurement of clinical carbon ion beams using a cross-correlation time-of-flight method with parallel-plate chambers.

Medical physics·2026
Same author

Multi-angle beam range measurement framework for carbon-ion radiotherapy using a commercial multi-layer ionization chamber.

Zeitschrift fur medizinische Physik·2026
Same author

High-resolution Annotated Dataset of Girvanella Boundstone Microfacies from the Xiannüdong Formation, China.

Scientific data·2026
Same author

Development and clinical applications of an all-in-one Monte Carlo-based independent dose calculation system for carbon-ion radiation therapy.

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)·2026
Same journal

Blood Eosinophil Count, Disease Severity, and Exacerbation Risk in Korean Patients with Bronchiectasis: A Retrospective Cohort Study.

Tuberculosis and respiratory diseases·2026
Same journal

Nationwide Incidence and Prevalence of Idiopathic Pulmonary Fibrosis in South Korea.

Tuberculosis and respiratory diseases·2026
Same journal

A Multicenter Registry for Rare Interstitial Lung Diseases in Korea: Baseline Characteristics and Clinical Outcomes.

Tuberculosis and respiratory diseases·2026
Same journal

Use of anticoagulants as a supportive measure in pulmonary hypertension: a narrative review.

Tuberculosis and respiratory diseases·2026
Same journal

Real-world safety of FF/UMEC/VI in patients with asthma or COPD, and clinical outcomes in COPD: post-marketing surveillance in Korea.

Tuberculosis and respiratory diseases·2026
Same journal

Recent Updates on Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration and Its Clinical Implications.

Tuberculosis and respiratory diseases·2026
See all related articles

Related Experiment Video

Updated: May 16, 2026

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

Bronchiectasis.

Changhwan Kim1, Dong-Gyu Kim

  • 1Department of Internal Medicine and Lung Research Institute, Hallym University College of Medicine, Chuncheon, Korea.

Tuberculosis and Respiratory Diseases
|December 14, 2012
PubMed
Summary
This summary is machine-generated.

Diagnosing bronchiectasis is rising globally. This review focuses on immunological causes of bronchiectasis, excluding cystic fibrosis, and discusses current management and treatment controversies.

Keywords:
BronchiectasisEtiologyImmunologic Deficiency SyndromesTherapeutics

Related Experiment Videos

Last Updated: May 16, 2026

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

Area of Science:

  • Pulmonology
  • Immunology
  • Medical Research

Background:

  • Bronchiectasis diagnosis is increasing worldwide.
  • Cystic fibrosis is a common cause, but non-cystic fibrosis causes are increasingly recognized.
  • Understanding the underlying cause is crucial for effective bronchiectasis management.

Purpose of the Study:

  • To review immunological abnormalities causing bronchiectasis in patients without cystic fibrosis.
  • To identify evidence-based current management strategies.
  • To discuss controversial aspects of bronchiectasis treatment.

Main Methods:

  • Literature review of recent research on bronchiectasis.
  • Focus on immunological causes and non-cystic fibrosis patient populations.
  • Analysis of current treatment guidelines and controversies.

Main Results:

  • Bronchiectasis has diverse causes beyond cystic fibrosis, with immunological factors playing a significant role.
  • Effective management hinges on accurate diagnosis of the underlying etiology.
  • Current treatment involves addressing the specific cause and managing symptoms, though controversies remain.

Conclusions:

  • Immunological abnormalities are important causes of bronchiectasis in non-cystic fibrosis patients.
  • Further research is needed to clarify optimal management strategies and resolve treatment controversies.
  • Early and accurate diagnosis of bronchiectasis etiology is paramount for patient outcomes.